Bhatia Kishor G. 4
4 · Lantern Pharma Inc. · Filed Jun 15, 2020
Insider Transaction Report
Form 4
Bhatia Kishor G.
Chief Scientific Officer
Transactions
- Award
Stock Option
2020-06-15+52,200→ 52,200 totalExercise: $15.00→ Common Stock (52,200 underlying)
Footnotes (1)
- [F1]Pursuant to the employment agreement between the Issuer and the Reporting Person as Chief Scientific Officer, the Reporting Person was granted stock options to purchase 52,200 shares of the Issuer's common stock upon the closing of the Issuer's initial public offering ("IPO") under the terms and conditions of the Issuer's Amended and Restated 2018 Equity Incentive Plan. The exercise price equals the price per share sold in the Issuer's offering. One-third of the options will vest 180 days from the closing of the Issuer's IPO (the "Grant Date"), with the remaining two-thirds of the options vesting in equal monthly increments over the period commencing the 181st day after the Grant Date and ending 30 months thereafter (or 36 months after the Grant Date). Under the Amended and Restated 2018 Equity Incentive Plan, the options may not be exercised after the tenth anniversary of the Grant Date.